Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2015 /
How is ganetespib regulating the response of tumour cells in lung cancer?

18th - 22nd Apr 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 30.04.15
Views: 1949
Rating:

Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA

Dr Golemis talks to ecancertv at AACR 2015 about the work she is doing towards identifying factors that regulate the response of tumour cells to ganetespib, a drug combination that is currently in clinical trials.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation